Grants and Contributions:
Title:
Bioanalytical method development and non-GLP safety studies for a bone-targeting drug
Agreement Number:
942888
Agreement Value:
$120,000.00
Agreement Date:
Dec 17, 2019 - Mar 31, 2020
Description:
This project will support the firm to develop analytical methods and obtain initial toxicology information for their lead compound that will be used to support future IND-enabling studies.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6T 1Z3
Reference Number:
172-2019-2020-Q4-942888
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
832032031
Recipient Type:
For-profit organization
Recipient's Legal Name:
Mesentech Inc.
Federal Riding Name:
Vancouver Quadra
Federal Riding Number:
59039
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54171